Croft S, Wong Y, Smith S, Flesch I, Tscharke D
J Virol. 2020; 94(20).
PMID: 32759313
PMC: 7527048.
DOI: 10.1128/JVI.01486-20.
Gallinaro A, Borghi M, Pirillo M, Cecchetti S, Bona R, Canitano A
Mol Ther Methods Clin Dev. 2020; 17:418-428.
PMID: 32154327
PMC: 7056611.
DOI: 10.1016/j.omtm.2020.01.013.
Perez-Zsolt D, Martinez-Picado J, Izquierdo-Useros N
Viruses. 2019; 12(1).
PMID: 31861617
PMC: 7019426.
DOI: 10.3390/v12010008.
Martin-Moreno A, Munoz-Fernandez M
Front Immunol. 2019; 10:2485.
PMID: 31708924
PMC: 6820366.
DOI: 10.3389/fimmu.2019.02485.
Tang-Huau T, Gueguen P, Goudot C, Durand M, Bohec M, Baulande S
Nat Commun. 2018; 9(1):2570.
PMID: 29967419
PMC: 6028641.
DOI: 10.1038/s41467-018-04985-0.
Antigen processing and presentation in HIV infection.
Boucau J, Le Gall S
Mol Immunol. 2018; 113:67-74.
PMID: 29636181
PMC: 6174111.
DOI: 10.1016/j.molimm.2018.03.027.
Major Histocompatibility Complex Class I (FLA-E*01801) Molecular Structure in Domestic Cats Demonstrates Species-Specific Characteristics in Presenting Viral Antigen Peptides.
Liang R, Sun Y, Liu Y, Wang J, Wu Y, Li Z
J Virol. 2017; 92(6).
PMID: 29263258
PMC: 5827386.
DOI: 10.1128/JVI.01631-17.
The HIV-1 integrase-LEDGF allosteric inhibitor MUT-A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivity.
Amadori C, van der Velden Y, Bonnard D, Orlov I, van Bel N, Le Rouzic E
Retrovirology. 2017; 14(1):50.
PMID: 29121950
PMC: 5680779.
DOI: 10.1186/s12977-017-0373-2.
HIV Fusion in Dendritic Cells Occurs Mainly at the Surface and Is Limited by Low CD4 Levels.
Chauveau L, Donahue D, Monel B, Porrot F, Bruel T, Richard L
J Virol. 2017; 91(21).
PMID: 28814521
PMC: 5640872.
DOI: 10.1128/JVI.01248-17.
Constitutive resistance to viral infection in human CD141 dendritic cells.
Silvin A, Yu C, Lahaye X, Imperatore F, Brault J, Cardinaud S
Sci Immunol. 2017; 2(13).
PMID: 28783704
PMC: 5749640.
DOI: 10.1126/sciimmunol.aai8071.
Dying cells actively regulate adaptive immune responses.
Yatim N, Cullen S, Albert M
Nat Rev Immunol. 2017; 17(4):262-275.
PMID: 28287107
DOI: 10.1038/nri.2017.9.
The role of Siglec-1 in HIV-1/macrophage interaction.
Jobe O, Kim J, Rao M
Macrophage (Houst). 2017; 3.
PMID: 28286869
PMC: 5341613.
SAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells.
Ayinde D, Bruel T, Cardinaud S, Porrot F, G Prado J, Moris A
J Virol. 2015; 89(14):6994-7006.
PMID: 25926647
PMC: 4473575.
DOI: 10.1128/JVI.00069-15.
Variable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape.
Dinter J, Duong E, Lai N, Berberich M, Kourjian G, Bracho-Sanchez E
PLoS Pathog. 2015; 11(3):e1004725.
PMID: 25781895
PMC: 4364612.
DOI: 10.1371/journal.ppat.1004725.
Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients.
Draborg A, Jacobsen S, Westergaard M, Mortensen S, Larsen J, Houen G
Lupus Sci Med. 2014; 1(1):e000015.
PMID: 25396062
PMC: 4225738.
DOI: 10.1136/lupus-2014-000015.
Different antigen-processing activities in dendritic cells, macrophages, and monocytes lead to uneven production of HIV epitopes and affect CTL recognition.
Dinter J, Gourdain P, Lai N, Duong E, Bracho-Sanchez E, Rucevic M
J Immunol. 2014; 193(9):4322-4334.
PMID: 25230751
PMC: 4201977.
DOI: 10.4049/jimmunol.1400491.
Understanding MHC class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccines.
van Montfoort N, van der Aa E, Woltman A
Front Immunol. 2014; 5:182.
PMID: 24795724
PMC: 4005948.
DOI: 10.3389/fimmu.2014.00182.
CD8+ T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants.
Pohlmeyer C, Buckheit 3rd R, Siliciano R, Blankson J
Retrovirology. 2013; 10:152.
PMID: 24330837
PMC: 3878989.
DOI: 10.1186/1742-4690-10-152.
Dendritic cells in progression and pathology of HIV infection.
Manches O, Frleta D, Bhardwaj N
Trends Immunol. 2013; 35(3):114-22.
PMID: 24246474
PMC: 3943663.
DOI: 10.1016/j.it.2013.10.003.
Primary CD8+ T cells from elite suppressors effectively eliminate non-productively HIV-1 infected resting and activated CD4+ T cells.
Buckheit 3rd R, Siliciano R, Blankson J
Retrovirology. 2013; 10:68.
PMID: 23816179
PMC: 3702406.
DOI: 10.1186/1742-4690-10-68.